SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007515
Filing Date
2019-08-07
Accepted
2019-08-07 17:21:49
Documents
77
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20190630x10q.htm 10-Q 2406903
2 EX-10.1 ptgx-20190630ex101076de1.htm EX-10.1 382261
3 EX-31.1 ptgx-20190630ex311fe728c.htm EX-31.1 12082
4 EX-31.2 ptgx-20190630ex31271e103.htm EX-31.2 10537
5 EX-32.1 ptgx-20190630ex3218cabe1.htm EX-32.1 12563
6 GRAPHIC ptgx20190630x10q001.jpg GRAPHIC 60330
  Complete submission text file 0001558370-19-007515.txt   9048682

Data Files

Seq Description Document Type Size
7 EX-101.INS ptgx-20190630.xml EX-101.INS 1918921
8 EX-101.SCH ptgx-20190630.xsd EX-101.SCH 54837
9 EX-101.CAL ptgx-20190630_cal.xml EX-101.CAL 59548
10 EX-101.DEF ptgx-20190630_def.xml EX-101.DEF 183348
11 EX-101.LAB ptgx-20190630_lab.xml EX-101.LAB 457042
12 EX-101.PRE ptgx-20190630_pre.xml EX-101.PRE 396098
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 191006491
SIC: 2834 Pharmaceutical Preparations